Evolution of Translational Omics Lessons Learned and the Path Forward (2012) / Chapter Skim
Currently Skimming:
Appendix F: Information Gathering Sessionsand Speakers
Appendix F: Information Gathering Sessionsand Speakers
Pages 319-322
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 319... ...
Working Group, and President and CEO, The Colorado Trust KATRINA KELNER, Editor, Translational Medicine, and Managing Editor, Research Journals, Science Magazine VÉRONIQUE KIERMER, Executive Editor and Head of Researcher Services, Nature Publishing Group SUMITHRA MANDREKAR, Associate Professor of Biostatistics, Division of Biomedical Statistics and Informatics, Mayo Clinic JOSEPH NEVINS, Barbara Levine University Professor of Breast Cancer Genomics, Institute for Genome Sciences and Policy, Duke University 319
|
From page 320... ...
320 EVOLUTION OF TRANSLATIONAL OMICS HAROLD PAZ, Chief Executive Officer, Penn State Milton S Hershey Medical Center, and Senior Vice President for Health Affairs and Dean, College of Medicine, Pennsylvania State University CHARLES PEROU, Professor of Genetics and Pathology, and Member, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill PETER PRONOVOST, Director, Division of Adult Critical Care Medicine, Director, Quality and Safety Research Group, and Medical Director, Center for Innovations in Quality Patient Care, Johns Hopkins University STEVEN SHAK, Chief Medical Officer, Genomic Health RICHARD SIMON, Chief, Biometric Research Branch, National Cancer Institute LAURA VAN ‘T VEER, Director, Applied Genomics, and Program Leader, Breast Oncology, Helen Diller Family Comprehensive Cancer Center SCOTT ZEGER, Professor of Biostatistics and Vice Provost for Research, Bloomberg School of Public Health, Johns Hopkins University COMMITTEE MEETING 3 – JUNE 30-JULY 1, 2011 LISA McSHANE, Mathematical Statistician, Biometric Research Branch, National Cancer Institute TELECONFERENCE 1 – AUGUST 4, 2011 WILLIAM SELLERS, Vice President and Global Head of Oncology, Novartis Institutes for BioMedical Research TELECONFERENCE 2 – AUGUST 15, 2011 JEFFREY DRAZEN, Editor-in-Chief, New England Journal of Medicine TELECONFERENCE 3 – AUGUST 19, 2011 ALBERTO GUTIERREZ, Director, Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, Food and Drug Administration PANEL DISCUSSION WITH DUKE UNIVERSITY FACULTY AND ADMINISTRATION – AUGUST 22, 2011 WILLIAM BARRY, Assistant Professor of Biostatistics and Bioinformatics
|
From page 321... ...
321 APPENDIX F ROBERT CALIFF, Vice Chancellor for Clinical Research and Director, Duke Translational Medicine Institute MICHAEL CUFFE, Vice President for Ambulatory Services, Chief Medical Officer for Duke University Health System JOHN FALLETTA, Professor of Pediatrics and Senior Chair, Institutional Review Board GEOFFREY GINSBURG, Director of Genomic Medicine, Institute for Genome Sciences and Policy MICHAEL KELLEY, Associate Professor of Medicine, Oncology, and Cancer Protocol Review Committee SALLY KORNBLUTH, James B Duke Professor of Pharmacology and Cancer Biology and Vice Dean for Research, Duke University Medical Center ROSS McKINNEY, Director, Clinical and Translational Research Ethics, Law, and Policy, Professor of Pediatrics, and Director, Trent Center for Bioethics, Humanities, and Medical History
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.